Last Updated: December 15, 2024

   
     

 
Featured Articles

This drug is the 'breakthrough of the year' — and it could mean the end of the HIV epidemic

NPR | December 12, 2024

Clinical trial reveals twice-yearly injection to be 96% effective in HIV prevention

FirstWord Pharma | November 29, 2024

Gilead Presents Full PURPOSE 2 Data Results for Twice-Yearly Lenacapavir for HIV Prevention at HIV Glasgow

Gilead | November 13, 2024

Lenacapavir poised to 'transform' HIV prevention

Healio | October 7, 2024

New HIV Prevention Drug Shows 100% Efficacy in Clinical Trial

Science Alert | July 10, 2024

Behind the counter: Switching to injectables for HIV

Medical News Today | March 13, 2024

One-pill-a-day HIV treatments

aidsmap | December 2023

   
News Updates

Global leaders in the HIV response call for access to long-acting medicines

UNAIDS | December 10, 2024

Weight Gain While Treating HIV: Why It Happens

WebMD | November 14, 2024

Code Pharma’s Gammora® Demonstrates Highly Favorable Outcomes Toward a Potential Cure for HIV

BusinessWire | November 12, 2024

Gilead and Merck Report Successful Phase 2 Results for Investigational Once-Weekly HIV Treatment

Contagion Live | November 11, 2024

Long-acting preexposure prophylaxis: early data on roll-out in the United States 

Curr Opin HIV AIDS | 2024 Nov 5

Shaping the Next Era of HIV Therapeutics and Care

POZ Magazine | October 30, 2024

FDA Approves New UTI Antibiotic

Conexiant | October, 25, 2024

Updated Coverage Guidance Under the Affordable Care Act: Long-Acting PrEP

HIV.gov | October 24, 2024

Gilead and Merck Announce Phase 2 Data Showing a Treatment Switch to an Investigational Oral Once-Weekly Combination Regimen of Islatravir...

BioSpace | October 21, 2024

Biden Sides with Insurers, Shifting More Costs to Patients

ADAP | October 17, 2024

ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries 

ViiV Healthcare | October 7, 2024

Biopharma firm Gilead announces lenacapavir licensing for HIV treatment 

The Indian Express | October 4, 2024

Gilead Signs Voluntary Licensing Agreements for Lenacapavir PrEP

POZ | October 4, 2024

HIV prevention: why a new injectable drug could be such a breakthrough

The Conversation | October 3, 2024

A Promising Injectable for HIV Prevention

Yale School of Medicine | October 3, 2024

Fact Sheet: Medicare Part B Coverage of Pre-exposure Prophylaxis (PrEP) for Human Immunodeficiency Virus (HIV) Prevention

CMS.gov | September 30, 2024

Virologic suppression rate and associated factors for third-line HIV treatment in Addis Ababa, Ethiopia

BMC Infectious Diseases - BioMed Central | September 28, 2024

Long-acting injectable lenacapavir continues to show promising results for HIV prevention 

World Health Organization (WHO) | September 26, 2024

Drug-Related Problems in HIV Treatment Failure

Cureus | September 21, 2024

New two-dose HIV vaccine strategy shows promise for stronger immune response

News Medical | September 20, 2024

Medicaid must prepare to cover twice-yearly HIV prevention injection

STAT | September 19, 2024

This preventive drug could be a 'game changer' in ending the HIV epidemic

NPR | September 17, 2024

Type 2 Diabetes Drug Metformin May Help Reduce Viral Reservoir in People with HIV

Healthline | September 16, 2024

The Significance of Antimicrobial Stewardship in Dentistry

Contagion Live | September 9, 2024

HIV antiretroviral therapy saves over a million lives each year

Our World in Data | September 2024

Investors can play 'pivotal role' in addressing antimicrobial resistance, report says

CIDRAP | August 30, 2024

Breakthrough HIV drug Lenacapavir Shows promising results in recent study

FOX5 | August 16, 2024

Reproductive-Aged Women With HIV Express Interest in Long-Acting ART Options

IDA | August 15, 2024

Sussex launches new online HIV medication service

BBC | August 11, 2024

Dovato (dolutegravir/lamivudine) - Uses, Side Effects, and More

WebMD | August 11, 2024

Doctor behind trial of HIV prevention drug recounts breakthrough moment

The Guardian | July 26, 2024

With PrEP Effort Lagging, Positive Results for Twice-Yearly Lenacapavir May Give a Lift

Managed Healthcare | July 25, 2024

Experts say a twice-yearly injection that offers 100% protection against HIV is ‘stunning’

AP | July 24, 2024

What is an Investigational HIV Drug?

NIH | July 23, 2024

HIV drug could be made for just $40 a year for every patient

The Guardian | July 23, 2024

CDC Releases Antimicrobial Resistant Threats Data From During 2021-2022

CDC | July 16, 2024

Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1

AACP Journals | July 15, 2024

ViiV Healthcare To Announce Data From Largest Head-To-Head Randomised Clinical Trial For 2-Drug Regimen Dovato Against 3-Drug...

ViiV Healthcare | July 15, 2024

Biden administration appeals jury finding in battle over patents for HIV prevention pills

STAT | July 8, 2024

Presentation: Implementation of Long-Acting Drugs for the Treatment and Prevention of HIV

IAS | July 23, 2034

A new way to prevent HIV delivers dramatic results in trial: PURPOSE 1

KRWG | July 3, 2024

   

 
           
2019 Archives 2020 Archives 2021 Archives 2022 Archives 2023 Archives 2024 Archives